Anpario (LON:ANP) Reaches New 1-Year High – Time to Buy?

Anpario plc (LON:ANP)’s stock price reached a new 52-week high during mid-day trading on Monday . The stock traded as high as GBX 460 ($5.59) and last traded at GBX 454.15 ($5.52), with a volume of 67520 shares traded. The stock had previously closed at GBX 458.89 ($5.58).

Wall Street Analysts Forecast Growth

Separately, Canaccord Genuity Group lifted their target price on Anpario from GBX 380 ($4.62) to GBX 500 ($6.08) and gave the company a “buy” rating in a research note on Tuesday, January 14th.

Anpario Stock Performance

The firm has a market capitalization of £76.80 million, a P/E ratio of 2,523.06 and a beta of 0.58. The company has a debt-to-equity ratio of 0.21, a current ratio of 6.15 and a quick ratio of 5.16. The stock’s 50 day moving average is GBX 370.03 and its two-hundred day moving average is GBX 325.13.

Insider Transactions at Anpario

In related news, insider Karen Prior sold 14,000 shares of Anpario stock in a transaction that occurred on Friday, December 13th. The shares were sold at an average price of GBX 380 ($4.62), for a total transaction of £53,200 ($64,704.45). 30.51% of the stock is owned by corporate insiders.

Anpario Company Profile

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.